药物对比
Donislecel vs Troglitazone
Donislecel（Lantidra）与Troglitazone对比：治疗1型糖尿病的细胞疗法 vs 已撤市的口服TZD治疗2型糖尿病。比较用途、风险及目前的可获得性。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when reviewing current cell-based options for type 1 diabetes against discontinued thiazolidinediones formerly used in type 2 diabetes.
结论
Donislecel and Troglitazone treat distinct diabetes types and Troglitazone is no longer available due to safety issues.
全部药物对比